For research use only.

Catalog No.S3085 Synonyms: MK-383

1 publication

Tirofiban Chemical Structure

CAS No. 144494-65-5

Tirofiban (MK-383) is a selective platelet GPIIb/IIIa antagonist which inhibits platelet aggregation with IC50 of 9 nM.

Selleck's Tirofiban has been cited by 1 publication

Purity & Quality Control

Choose Selective Integrin Inhibitors

Biological Activity

Description Tirofiban (MK-383) is a selective platelet GPIIb/IIIa antagonist which inhibits platelet aggregation with IC50 of 9 nM.
GPIIb/IIIa [1]
In vitro

Tirofiban (MK-383, Aggrastat) is a nonpeptide derivative of tyrosine that selectively inhibits the GP-IIb/IIIa receptor, with minimal effects on the ɑvβ3 vitronectin receptor. [1][2] It inhibits platelet aggregation of gel-filtered platelets induced by 10 μM ADP with IC50 of 9 nM, but the IC50 for inhibition of human umbilical vein adhesion to vitronectin, which depends on ɑvβ3 vitronectin receptors, is 62 μmol/L. [2]

In vivo

Tirofiban (10 to 500 mg/kg or 360-min continuous i.v. infusions of 1 to 10 micrograms/kg/min) inhibits platelet aggregation responses to ADP and collagen in canine models. [3] When administered to humans at 0.15μg/kg/min for 4 h, Tirofiban produced a 2.5-fold increase in bleeding time and 97% inhibition of ADP-induced platelet aggregation. [4][5]


Solubility (25°C)

In vitro DMSO 0.005 mg/mL (0.01 mM)
Water Insoluble
Ethanol Insoluble

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 440.6


CAS No. 144494-65-5
Storage powder
in solvent
Synonyms MK-383

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Dosage mg/kg Average weight of animals g Dosing volume per animal ul Number of animals
Step 2: Enter the in vivo formulation ()
% DMSO % % Tween 80 % ddH2O

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (mg) = Concentration (mM) × Volume (mL) × Molecular Weight (g/mol)

  • Mass
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and SDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment interventions Conditions Sponsor/Collaborators Start Date Phases
NCT03797729 Recruiting Drug: Tirofiban|Drug: Normal saline ST Elevation Myocardial Infarction Shanghai Zhongshan Hospital May 14 2019 Phase 4
NCT03048019 Unknown status Drug: Tirofiban|Drug: Cangrelor Non-ST Elevation Myocardial Infarction (NSTEMI) Inova Health Care Services August 23 2017 --
NCT01766154 Completed Drug: Tirofiban Renal Insufficiency Medicure January 2013 Phase 1
NCT01336348 Completed Drug: Prasugrel|Drug: Tirofiban ST Segment Elevation Myocardial Infarction Università degli Studi di Ferrara April 2010 Phase 3
NCT00407771 Unknown status Drug: Tirofiban Coronary Artery Disease Jordan Hospital|Merck Sharp & Dohme Corp. November 2007 Phase 4
NCT00538317 Completed Drug: tirofiban Acute Myocardial Infarction Hospices Civils de Lyon July 2007 Phase 4

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

Integrin Signaling Pathway Map

Tags: buy Tirofiban | Tirofiban ic50 | Tirofiban price | Tirofiban cost | Tirofiban solubility dmso | Tirofiban purchase | Tirofiban manufacturer | Tirofiban research buy | Tirofiban order | Tirofiban mouse | Tirofiban chemical structure | Tirofiban mw | Tirofiban molecular weight | Tirofiban datasheet | Tirofiban supplier | Tirofiban in vitro | Tirofiban cell line | Tirofiban concentration | Tirofiban nmr
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID